The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and embedded within those processes are two things that are absolutely necessary you can't approve a drug unless you can confirm that it is safe and that's done primarily in Phase one but the safety monitoring continues into phase 2 and phase 3 and even beyond into post marketing and then the second thing that becomes more important by phase 2 and then again in phase 3 is efficacy does it work
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.